EMX1: A Potential Drug Target Or Biomarker for Cancer (G2016)
EMX1: A Potential Drug Target Or Biomarker for Cancer
EMX1, also known as empty spiracles homeobox 1, is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 6 and encodes a protein known as ESCRIPT, which is a transcription factor that plays a role in the development and maintenance of tissues in the body.
EMX1 has been shown to be involved in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Studies have also suggested that EMX1 may be involved in the development of other diseases, including heart disease and neurodegenerative disorders.
One of the reasons why EMX1 has generated so much interest is its location on chromosome 6, which makes it a potential candidate for genetic modification. This is because changes in the DNA sequence of a gene located on chromosome 6 have been associated with a number of diseases, including cancer.
In addition to its potential as a drug target or biomarker, EMX1 has also been shown to be involved in the development of cancer in animals. For example, studies have found that EMX1-deficient mice have an increased risk of developing breast cancer compared to their genetically modified counterparts.
Furthermore, EMX1 has been shown to be involved in the regulation of cell growth and differentiation. This is important because changes in the regulation of cell growth and differentiation have been implicated in the development of many diseases, including cancer.
In conclusion, EMX1 is a gene that has generated a lot of interest due to its potential as a drug target or biomarker for the treatment of cancer. Its location on chromosome 6 and its involvement in the regulation of cell growth and differentiation make it an attractive candidate for genetic modification. Further research is needed to fully understand the role of EMX1 in the development and progression of cancer and other diseases.
Protein Name: Empty Spiracles Homeobox 1
Functions: Transcription factor, which in cooperation with EMX2, acts to generate the boundary between the roof and archipallium in the developing brain. May function in combinations with OTX1/2 to specify cell fates in the developing central nervous system
More Common Targets
EMX2 | EMX2OS | EN1 | EN2 | ENAH | ENAM | ENC1 | ENDOD1 | ENDOG | Endogenous Retrovirus group K Env polyprotein (ERVK) | Endogenous retrovirus group K member 25 Pol protein-like, transcript variant X1 | EndoGlyx-1 | Endoplasmic reticulum collagen prolyl 3-hydroxylation complex | Endothelin receptor | Endothelin-Converting Enzymes (ECE) | Endothiapepsin | ENDOU | ENDOV | ENG | ENGASE | ENHO | ENKD1 | ENKUR | ENO1 | ENO1-AS1 | ENO1P1 | ENO1P4 | ENO2 | ENO3 | ENO4 | ENOPH1 | eNoSC Complex | ENOSF1 | ENOX1 | ENOX1-AS2 | ENOX2 | ENPEP | ENPP1 | ENPP2 | ENPP3 | ENPP4 | ENPP5 | ENPP6 | ENPP7 | ENPP7P10 | ENPP7P12 | ENPP7P7 | ENSA | ENSAP2 | ENTHD1 | ENTPD1 | ENTPD1-AS1 | ENTPD2 | ENTPD3 | ENTPD3-AS1 | ENTPD4 | ENTPD5 | ENTPD6 | ENTPD7 | ENTPD8 | ENTR1 | ENTREP1 | ENTREP2 | ENTREP3 | env | ENY2 | EOGT | EOLA1 | EOLA1-DT | EOLA2 | EOLA2-DT | EOMES | EP300 | EP300-AS1 | EP400 | EP400P1 | EPAS1 | EPB41 | EPB41L1 | EPB41L1-AS1 | EPB41L2 | EPB41L3 | EPB41L4A | EPB41L4A-AS1 | EPB41L4A-DT | EPB41L4B | EPB41L5 | EPB42 | EPC1 | EPC2 | EPCAM | EPCAM-DT | EPDR1 | EPG5 | EPGN | EPHA1 | EPHA1-AS1 | EPHA10 | EPHA2 | EPHA2-AS1